A Helicobacter pylori-associated insulin resistance in asymptomatic sedentary young men does not correlate with inflammatory markers and urine levels of 8-iso-PGF₂-α or 1,4-dihydroxynonane mercapturic acid

References

• Buzas, G.M., 2014. Metabolic consequences of Helicobacter pylori infection and eradication. World Journal of Gastroenterology, 20, 5226–5234.
   PubMed Web of Science ®Google Scholar
• Cardaropoli, S., et al., 2015. Helicobacter pylori seropositivity and pregnancy-related diseases: a prospective cohort study. Journal of Reproductive Immunology, 109, 41–47.
   PubMed Web of Science ®Google Scholar
• Chen, L.W., et al., 2015. Helicobacter pylori infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: a community-based study. PLoS One, 10, e0128671.
   PubMed Web of Science ®Google Scholar
• Cherkas, A., et al., 2009. Persistent accumulation of 4-hydroxynonenal-protein adducts in gastric mucosa after Helicobacter pylori eradication. Collegium Antropologicum, 33, 815–821.
   PubMed Web of Science ®Google Scholar
• Cherkas, A., et al., 2015. The correlations of glycated hemoglobin and carbohydrate metabolism parameters with heart rate variability in apparently healthy sedentary young male subjects. Redox Biology, 5, 301–307.
   PubMed Web of Science ®Google Scholar
• Cherkas, A., et al., 2016. Helicobacter pylori in sedentary men is linked to higher heart rate, sympathetic activity, and insulin resistance but not inflammation or oxidative stress. Croatian Medical Journal, 57 (2), 141–149.
   PubMed Web of Science ®Google Scholar
• Cherkas, A., and Golota, S., 2014. An intermittent exhaustion of the pool of glycogen in the human organism as a simple universal health promoting mechanism. Medical Hypotheses, 82 (3), 387–389.
   PubMed Web of Science ®Google Scholar
• Cherkas, A., and Yatskevych, O., 2014. The amplitude of heart rate oscillations is dependent on metabolic status of sinoatrial node cells. OA Medical Hypothesis, 2, 8.
   Google Scholar
• Cherkas, A., and Zhuraev, R., 2016. A marked decrease in heart rate variability in Marfan syndrome patients with confirmed FBN1 mutations. Cardiology Journal, 23 (1), 23–33.
   PubMed Web of Science ®Google Scholar
• Collins, A.R., et al., 2008. The comet assay: topical issues. Mutagenesis, 23 (3), 143–151.
   PubMed Web of Science ®Google Scholar
• Dogan, Z., et al., 2015. The effect of Helicobacter pylori eradication on insulin resistance and HbA1c level in people with normal glucose levels: a prospective study. Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, 159, 242–245.
   PubMed Web of Science ®Google Scholar
• Feng, B., et al., 2016. Silymarin alleviates hepatic oxidative stress and protects against metabolic disorders in high-fat diet-fed mice. Free Radical Research, 50 (3), 314–327.
   PubMed Web of Science ®Google Scholar
• Franceschi, F., et al., 2015. Extragastric Diseases and Helicobacter pylori. Helicobacter, 20 Suppl 1, 40–46.
   PubMed Web of Science ®Google Scholar
• Gueraud, F., et al., 2006. Enzyme immunoassay for a urinary metabolite of 4-hydroxynonenal as a marker of lipid peroxidation. Free Radical Biology & Medicine, 40, 54–62.
   PubMed Web of Science ®Google Scholar
• Handa, O., Naito, Y., and Yoshikawa, T., 2010. Helicobacter pylori: a ROS-inducing bacterial species in the stomach. Inflammation Research, 59 (12), 997–1003.
   PubMed Web of Science ®Google Scholar
• Hardbower, D.M., et al., 2013. Chronic inflammation and oxidative stress: the smoking gun for Helicobacter pylori-induced gastric cancer?. Gut Microbes, 4 (6), 475–481.
   PubMed Web of Science ®Google Scholar
• Hardbower, D.M., Peek, R.M., JR., and Wilson, K.T., 2014. At the Bench: Helicobacter pylori, dysregulated host responses, DNA damage, and gastric cancer. Journal of Leukocyte Biology, 96 (2), 201–212.
   PubMed Web of Science ®Google Scholar
• He, C., et al., 2016. Helicobacter pylori infection aggravates diet-induced insulin resistance in association with gut microbiota of mice. EBioMedicine, 12, 247–254.
   PubMed Web of Science ®Google Scholar
• Kim, H.G., et al., 2016. Binding, antioxidant and anti-proliferative properties of bioactive compounds of sweet paprika (Capsicum annuum L.). Plant Foods for Human Nutrition, 71 (2), 129–136.
   PubMed Web of Science ®Google Scholar
• Kasai, C., et al., 2016. Changes in plasma ghrelin and leptin levels in patients with peptic ulcer and gastritis following eradication of Helicobacter pylori infection. BMC Gastroenterology, 16, 119.
   PubMed Web of Science ®Google Scholar
• Kirpich, I.A., Marsano, L.S., and McClain, C.J., 2015. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease. Clinical Biochemistry, 48 (13-14), 923–930.
   PubMed Web of Science ®Google Scholar
• Kountouras, J., et al., 2017. Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis. Free Radical Research, 51 (1), 73–79.
   PubMed Web of Science ®Google Scholar
• Lane, J.A., et al., 2011. Randomised clinical trial: Helicobacter pylori eradication is associated with a significantly increased body mass index in a placebo-controlled study. Alimentary Pharmacology & Therapeutics, 33, 922–929.
   PubMed Web of Science ®Google Scholar
• Lecube, A., et al., 2016. The role of morbid obesity in the promotion of metabolic disruptions and non-alcoholic steatohepatitis by Helicobacter pylori. PLoS One, 11 (11), e0166741.
   PubMed Web of Science ®Google Scholar
• Lim, S., Oh, T.J., and Koh, K.K., 2015. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. International Journal of Cardiology, 201, 408–414.
   PubMed Web of Science ®Google Scholar
• Lin, Y., et al., 2015. Helicobacter Pylori infection and risk of death from cardiovascular disease among the Japanese population: a nested case-control study within the JACC Study. Journal of Atherosclerosis and Thrombosis, 22 (11), 1207–1213.
   PubMed Web of Science ®Google Scholar
• Longo-Mbenza, B., Nsenga, J.N., and Ngoma, D.V., 2007. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. International Journal of Cardiology, 121 (3), 229–238.
   PubMed Web of Science ®Google Scholar
• Ma, Y., et al., 2013. Relation between gastric cancer and protein oxidation, DNA damage, and lipid peroxidation. Oxidative Medicine and Cellular Longevity, 2013, 543760.
   PubMed Web of Science ®Google Scholar
• Mentis, A., Lehours, P., and Mégraud, F., 2015. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter, 20, 1–7.
   PubMed Web of Science ®Google Scholar
• Milne, G.L., Dai, Q., and Roberts, L.J., 2015. The isoprostanes-25 years later. Biochimica Et Biophysica Acta, 1851 (4), 433–445.
   PubMed Web of Science ®Google Scholar
• Okin, D., and Medzhitov, R., 2016. The effect of sustained inflammation on hepatic mevalonate pathway results in hyperglycemia. Cell, 165 (2), 343–356.
   PubMed Web of Science ®Google Scholar
• Peiro, G., et al., 2005. Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation. Biofactors, 24 (1-4), 89–96.
   PubMed Web of Science ®Google Scholar
• Polyzos, S.A., et al., 2013. Helicobacter pylori infection in patients with nonalcoholic fatty liver disease. Metabolism, 62 (1), 121–126.
   PubMed Web of Science ®Google Scholar
• Santos, A.C., Ebrahim, S., and Barros, H. 2008. Gender, socio-economic status and metabolic syndrome in middle-aged and old adults. BMC Public Health, 8, 62.
   PubMed Web of Science ®Google Scholar
• Schaur, R.J., et al., 2015. 4-Hydroxy-nonenal-A Bioactive Lipid Peroxidation Product. Biomolecules, 5 (4), 2247–2337.
   PubMed Web of Science ®Google Scholar
• Semen, K.O., et al., 2010. Interval hypoxic training in complex treatment of Helicobacter pylori-associated peptic ulcer disease. Acta Biochimica Polonica, 57, 199–208.
   PubMed Web of Science ®Google Scholar
• Senatore, F.J., Wilmot, J., and Birk, J.W., 2016. Helicobacter pylori treatment: still a work in progress. Postgraduate Medicine, 128 (1), 152–157.
   PubMed Web of Science ®Google Scholar
• Sgouras, D.N., Trang, T.T., and Yamaoka, Y., 2015. Pathogenesis of Helicobacter pylori infection. Helicobacter, 20 (Suppl 1), 8–16.
   PubMed Web of Science ®Google Scholar
• Shin, D.W., et al., 2012. Association between metabolic syndrome and Helicobacter pylori infection diagnosed by histologic status and serological status. Journal of Clinical Gastroenterology, 46, 840–845.
   PubMed Web of Science ®Google Scholar
• Sparks, L.M., et al., 2016. Effects of 12 months of caloric restriction on muscle mitochondrial function in healthy individuals. The Journal of Clinical Endocrinology & Metabolism, 102 (1), 111–121.
   Web of Science ®Google Scholar
• Stelmakh, A., Abrahamovych, O., and Cherkas, A., 2016. Highly purified calf hemodialysate (Actovegin(R)) may improve endothelial function by activation of proteasomes: A hypothesis explaining the possible mechanisms of action. Medical Hypotheses, 95, 77–81.
   PubMed Web of Science ®Google Scholar
• Sumida, Y., et al., 2015. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease. Journal of Gastroenterology, 50, 996–1004.
   PubMed Web of Science ®Google Scholar
• Tice, R.R., et al., 2000. Single cell gel/comet assay: guidelines for in vitro and in vivo genetic toxicology testing. Environmental and Molecular Mutagenesis, 35 (3), 206–221.
   PubMed Web of Science ®Google Scholar
• Upala, S., et al., 2016. Association between Helicobacter pylori infection and metabolic syndrome: a systematic review and meta-analysis. Journal of Digestive Diseases, 17 (7), 433–440.
   PubMed Web of Science ®Google Scholar
• Wallace, T.M., Levy, J.C., and Matthews, D.R., 2004. Use and abuse of HOMA modeling. Diabetes Care, 27 (6), 1487–1495.
   PubMed Web of Science ®Google Scholar
• Waluga, M., et al., 2015. From the stomach to other organs: Helicobacter pylori and the liver. World Journal of Hepatology, 7 (18), 2136–2146.
   PubMedGoogle Scholar
• Yelisyeyeva, O., et al., 2009. Study of aerobic metabolism parameters and heart rate variability and their correlations in elite athletes: a modulatory effect of amaranth oil. Clinical and Experimental Medical Journal, 3 (2), 293–307.
   Google Scholar
• Yelisyeyeva, O., et al., 2008. The distribution of 4-hydroxynonenal-modified proteins in gastric mucosa of duodenal peptic ulcer patients. Free Radical Research, 42 (3), 205–211.
   PubMed Web of Science ®Google Scholar